Purpose of Review <p>This review aims to delve into the management of fungal infections, with a focus on optimizing antifungal therapy while minimizing drug interactions. It underscores the challenges posed by drug-resistant pathogens and the complex pharmacokinetics of antifungal agents.</p> Recent Findings <p>The landscape of antifungal treatment has broadened with the introduction of new therapies; however, drug resistance and interactions continue to pose significant challenges. Innovative combination therapies, incorporating both novel and repurposed drugs, show promise in enhancing treatment efficacy and reducing resistance. The antifungal interaction database is emphasized as a crucial tool for navigating these complexities.</p> Summary <p>Combination antifungal therapy is revolutionizing the treatment of invasive fungal infections by offering broader coverage and reducing toxicity. Achieving successful treatment outcomes requires a comprehensive understanding of pharmacokinetics and pharmacodynamics, highlighting the necessity for clinical application. As fungal infections rise, particularly among immunocompromised patients, ongoing research and clinical trials are essential for developing groundbreaking treatments and advancing patient care.</p>